16 May 2023
Learnings and perspectives from the COAPT trial, 5-year follow-up
Sponsored by Abbott
Summary
Francesco Maisano and Lars Sondergaard meet up between 2 sessions of EuroPCR 2023 to discuss the 5-year results of the COAPT trial and share their key messages with us.
One of the main points to note is that 95 % of patients treated with MitraClip experiencing reduced MR, after 5 years, demonstrating the durability of the therapy...
Discover the other highlights in this not-to-be-missed video interview!
This interview was filmed at EuroPCR 2023: see more videos here!